Viral interactions with the nuclear transport machinery: Discovering and disrupting pathways

IUBMB Life

Volumn 57, Issue 2, 2005, Pages 65-72

  Fontoura, Beatriz M A ^a,b   Faria, Paula A ^a   Nussenzveig, Daniel R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Exportin; Importin; Interferon; Karyopherin; Nuclear pore complex; Nuclear transport; TAP; VSV

Indexed keywords

KARYOPHERIN ALPHA; KARYOPHERIN BETA; MATRIX PROTEIN; MESSENGER RNA; NUCLEOPORIN; NUCLEOPORIN 153; NUCLEOPORIN 62; PROTEIN P15; PROTEIN RAE1; RAN PROTEIN; SMALL NUCLEAR RNA; UNCLASSIFIED DRUG; VIRUS RNA;

ADENOVIRUS; CELL NUCLEUS MEMBRANE; COMPLEX FORMATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR TRANSPORT; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN DNA BINDING; PROTEIN RNA BINDING; REVIEW; RNA TRANSPORT; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION;

ACTIVE TRANSPORT, CELL NUCLEUS; KARYOPHERINS; MODELS, BIOLOGICAL; MOLECULAR PROBE TECHNIQUES; NUCLEAR PORE; PROTEINS; RNA; VIRAL PHYSIOLOGY;

MASON-PFIZER MONKEY VIRUS; MONKEY VIRUS; POLIOVIRUS;

EID: 18244401122     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540500078608     Document Type: Review

References (52)

1. Cullen, B. R. (2003) Nuclear RNA export. J. Cell Sci. 116, 587-597.
2. Rout, M. P., Aitchison, J. D., Magnasco, M. O., and Chait, B. T. (2003) Virtual gating and nuclear transport: the hole picture. Trends Cell Biol. 13, 622-628.
3. Cronshaw, J. M., Krutchinsky, A. N., Zhang, W., Chait, B. T., and Matunis, M. J. (2002) Proteomic analysis of the mammalian nuclear pore complex. J. Cell Biol. 158, 915-927.
4. Rout, M. P., and Aitchison, J. D. (2001) The nuclear pore complex as a transport machine. J. Biol. Chem 276, 16593-16596.
5. Kau, T. R., Way, J. C., and Silver, P. A. (2004) Nuclear transport and cancer: from mechanism to intervention. Nat. Rev. Cancer 4, 106-117.
6. Suntharalingam, M., and Wente, S. R. (2003) Peering through the pore: nuclear pore complex structure, assembly, and function. Dev. Cell 4, 775-789.
7. Vasu, S. K., and Forbes, D. J. (2001) Nuclear pores and nuclear assembly. Curr. Opin. Cell Biol. 13, 363-375.
8. Weis, K. (2003) Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell 112, 441-451.
9. Fried, H., and Kutay, U. (2003) Nucleocytoplasmic transport: taking an inventory. Cell Mol. Life Sci 60, 1659-1688.
10. Jakel, S., and Gorlich, D. (1998) Importin beta, transportin, RanBP5 and RanBP7 mediate nuclear import of ribosomal proteins in mammalian cells. Embo J. 17, 4491-4502.
11. Xu, L., Alarcon, C., Col, S., and Massague, J. (2003) Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. J. Biol. Chem. 278, 42569-42577.
12. Fontoura, B. M., Blobel, G., and Yaseen, N. R. (2000) The nucleoporin Nup98 is a site for GDP/GTP exchange on ran and termination of karyopherin beta 2-mediated nuclear import. J. Biol. Chem. 275, 31289-31296.
13. Cole, C. N., and Hammell, C. M. (1998) Nucleocytoplasmic transport: driving and directing transport. Curr. Biol. 8, R368-372.
14. Gustin, K. E., and Sarnow, P. (2001) Effects of poliovirus infection on nucleocytoplasmic trafficking and nuclear pore complex composition. Embo J. 20, 240-249.
15. Gustin, K. E. (2003) Inhibition of nucleo-cytoplasmic trafficking by RNA viruses: targeting the nuclear pore complex. Virus Res. 95, 35-44.
16. Petersen, J. M., Her, L. S., and Dahlberg, J. E. (2001) Multiple vesiculoviral matrix proteins inhibit both nuclear export and import. Proc. Natl. Acad. Sci. USA 98, 8590-8595.
17. Faria, P. A., Chakraborty, P., Levay, A., Barber, G. N., Ezelle, H. J., Enninga, J., Arana, C., van Deursen, J., and Fontoura, B. M. (2005) VSV Disrupts the Rae1/mrnp41 mRNA Nuclear Export Pathway. Mol. Cell 17, 93-102.
18. Chung, K. M., Lee, J., Kim, J. E., Song, O. K., Cho, S., Lim, J., Seedorf, M., Hahm, B., and Jang, S. K. (2000) Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin beta3. J. Virol. 74, 5233-5241.
19. Fornerod, M., Ohno, M., Yoshida, M., and Mattaj, I. W. (1997) CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90, 1051-1060.
20. Stade, K., Ford, C. S., Guthrie, C., and Weis, K. (1997) Exportin 1 (Crm1p) is an essential nuclear export factor. Cell 90, 1041-1050.
21. Malim, M. H., Bohnlein, S., Hauber, J., and Cullen, B. R. (1989) Functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function. Cell 58, 205-214.
22. Malim, M. H., Hauber, J., Le, S. Y., Maizel, J. V., and Cullen, B. R. (1989) The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254-257.
23. Malim, M. H., Tiley, L. S., McCarn, D. F., Rusche, J. R., Hauber, J., and Cullen, B. R. (1990) HIV-1 structural gene expression requires binding of the Rev transactivator to its RNA target sequence. Cell 60, 675-683.
24. Bray, M., Prasad, S., Dubay, J. W., Hunter, E., Jeang, K. T., Rekosh, D., and Hammarskjold, M. L. (1994) A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA 91, 1256-1260.
25. Gruter, P., Tabernero, C., von Kobbe, C., Schmitt, C., Saavedra, C., Bachi, A., Wilm, M., Felber, B. K., and Izaurralde, E. (1998) TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol. Cell 1, 649-659.
26. Segref, A., Sharma, K., Doye, V., Hellwig, A., Huber, J., Luhrmann, R., and Hurt, E. (1997) Mex67p, a novel factor for nuclear mRNA export, binds to both poly(A) + RNA and nuclear pores. Embo J. 16, 3256-3271.
27. Yoon, D. W., Lee, H., Seol, W., DeMaria, M., Rosenzweig, M., and Jung, J. U. (1997) Tap: a novel cellular protein that interacts with top of herpesvirus saimiri and induces lymphocyte aggregation. Immunity 6, 571-582.
28. Bachi, A., Braun, I. C., Rodrigues, J. P., Pante, N., Ribbeck, K., von Kobbe, C., Kutay, U., Wilm, M., Gorlich, D., Carmo-Fonseca, M., and Izaurralde, E. (2000) The C-terminal domain of TAP interacts with the nuclear pore complex and promotes export of specific CTE-bearing RNA substrates. Rna 6, 136-158.
29. Stutz, F., and Izaurralde, E. (2003) The interplay of nuclear mRNP assembly, mRNA surveillance and export. Trends Cell Biol. 13, 319-327.
30. Forler, D., Rabut, G., Ciccarelli, F. D., Herold, A., Kocher, T., Niggeweg, R., Bork, P., Ellenberg, J., and Izaurralde, E. (2004) RanBP2/Nup358 provides a major binding site for NXF1-p15 dimers at the nuclear pore complex and functions in nuclear mRNA export. Mol. Cell Biol. 24, 1155-1167.
31. Radu, A., Moore, M. S., and Blobel, G. (1995) The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex. Cell 81, 215-222.
32. Fontoura, B. M., Dales, S., Blobel, G., and Zhong, H. (2001) The nucleoporin Nup98 associates with the intranuclear filamentous protein network of TPR. Proc. Natl. Acad. Sci. USA 98, 3208-3213.
33. Powers, M. A., Macaulay, C., Masiarz, F. R., and Forbes, D. J. (1995) Reconstituted nuclei depleted of a vertebrate GLFG nuclear pore protein, p97, import but are defective in nuclear growth and replication. J. Cell Biol. 128, 721-736.
34. Wu, J., Matunis, M. J., Kraemer, D., Blobel, G., and Coutavas, E. (1995) Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich region. J. Biol. Chem. 270, 14209-14213.
35. Blevins, M. B., Smith, A. M., Phillips, E. M., and Powers, M. A. (2003) Complex formation among the RNA export proteins Nup98, Rae1/Gle2, and TAP. J. Biol. Chem. 278, 20979-20988.
36. Murphy, R., Watkins, J. L., and Wente, S. R. (1996) GLE2, a Saccharomyces cerevisiae homologue of the Schizosaccharomyces pombe export factor RAE1, is required for nuclear pore complex structure and function. Mol. Biol. Cell 7, 1921-1937.
37. Pritchard, C. E., Fornerod, M., Kasper, L. H., and van Deursen, J. M. (1999) RAE1 is a shuttling mRNA export factor that binds to a GLEBS-like NUP98 motif at the nuclear pore complex through multiple domains. J. Cell Biol. 145, 237-254.
38. Powers, M. A., Forbes, D. J., Dahlberg, J. E., and Lund, E. (1997) The vertebrate GLFG nucleoporin, Nup98, is an essential component of multiple RNA export pathways. J. Cell Biol. 136, 241-150.
39. Her, L. S., Lund, E., and Dahlberg, J. E. (1997) Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 276, 1845-1848.
40. von Kobbe, C., van Deursen, J. M., Rodrigues, J. P., Sitterlin, D., Bachi, A., Wu, X., Wilm, M., Carmo-Fonseca, M., and Izaurralde, E. (2000) Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol. Cell 6, 1243-1252.
41. Enninga, J., Levy, D. E., Blobel, G., and Fontoura, B. M. (2002) Role of nucleoporin induction in releasing an mRNA nuclear export block. Science 295, 1523-1525.
42. Fernandez, M., Porosnicu, M., Markovic, D., and Barber, G. N. (2002) Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease. J. Virol. 76, 895-904.
43. Balachandran, S., and Barber, G. N. (2004) Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell 5, 51-65.
44. Stojdl, D. F., Lichty, B. D., tenOever, B. R., Paterson, J. M., Power, A. T., Knowles, S., Marius, R., Reynard, J., Poliquin, L., Atkins, H., Brown, E. G., Durbin, R. K., Durbin, J. E., Hiscott, J., and Bell, J. C. (2003) VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4, 263-275.
45. Obuchi, M., Fernandez, M., and Barber, G. N. (2003) Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity. J. Virol. 77, 8843-8856.
46. Balachandran, S., Porosnicu, M., and Barber, G. N. (2001) Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or Myc function and involves the induction of apoptosis. J. Virol. 75, 3474-3479.
47. Stojdl, D. F., Litch, S., Knowles, S., Marius, R., Atkins, H., Sonenberg, N., and Bell, J. C. (2000) Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6, 821-825.
48. Durbin, J. E., Hackenmiller, R., Simon, M. C., and Levy, D. E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
49. Malik, P., Blackbourn, D. J., and Clements, J. B. (2004) The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor. J. Biol. Chem. 279, 33001-33011.
50. Koffa, M. D., Clements, J. B., Izaurralde, E., Wadd, S., Wilson, S. A., Mattaj, I. W., and Kuersten, S. (2001) Herpes simplex virus ICP27 protein provides viral mRNAs with access to the cellular mRNA export pathway. Embo J. 20, 5769-5778.
51. Chen, I. H., Sciabica, K. S., and Sandri-Goldin, R. M. (2002) ICP27 interacts with the RNA export factor Aly/REF to direct herpes simplex virus type 1 intronless mRNAs to the TAP export pathway. J. Virol. 76, 12877-12889.
52. Flint, S. J., and Gonzalez, R. A. (2003) Regulation of mRNA production by the adenoviral E1B 55-kDa and E4 Orf6 proteins. Curr. Top. Microbiol. Immunol. 272, 287-330.